Georgia patients now have a wider path into the state’s medical cannabis program. Georgia Governor Brian Kemp signed SB 220, the Putting Georgia’s Patients First Act, which changes who may qualify, how approved patients may take medical cannabis, and how THC limits are measured.
The bill does not address recreational cannabis. Instead, it focuses on patients who may need medical cannabis for recognized health conditions and gives Georgia’s program clearer, broader rules for supervised access.
SB 220 Expands Medical Cannabis Access In Georgia
SB 220 gives Georgia’s medical cannabis program a wider reach while keeping it within a regulated medical framework. The law adds new patient access points and updates several rules that affected how patients qualified and what products they could use.
For you, the most important change is that the bill focuses on medical needs. It does not legalize recreational cannabis, and Governor Kemp directly addressed that concern in his signing statement. He said the question of recreational use was not part of the bill he signed.
The bill also changes the language in Georgia law from “low THC oil” to “medical cannabis.” That wording matters because the program now covers more than one narrow product category. It better reflects the medical cannabis products available to approved patients, including oils, tinctures, capsules, lozenges, topicals, transdermal patches, and now vaporized products for certain adults.
Lupus Is Now A Qualifying Condition
One of the clearest patient-focused changes in SB 220 is the addition of lupus as a qualifying condition. This means patients diagnosed with lupus may now be able to seek legal access to medical cannabis through Georgia’s program, as long as they meet the state’s requirements.
Lupus can bring serious daily symptoms, including pain, inflammation, fatigue, and other health challenges. By adding it to the qualifying condition list, Georgia recognizes that more patients may need physician-guided options when standard care does not fully control their symptoms.
The new law expanding medical marijuana access was among several crucial Senate bills affecting medical marijuana in Georgia. SB 220 builds on the conditions already included in Georgia’s program. These include cancer, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, ALS, autism spectrum disorder, intractable pain, and other approved conditions. For patients who live with chronic illness, this change may create a more realistic path to care without waiting for their condition to reach a more severe point.
The New Law Removes Severe or End-Stage Requirements For Many Conditions
SB 220 also changes how certain patients qualify. Before this bill, some conditions had to meet severe or end-stage requirements before a patient could enter the medical cannabis program. The new law removes that requirement for many conditions.
That change is important because it may allow patients to speak with a qualified physician earlier in their care journey for safe medical cannabis use. Instead of waiting until a condition becomes more advanced, you may have a chance to discuss medical cannabis when symptoms are already affecting your quality of life.
Key updates in this part of the bill include:
- Many patients no longer need to meet a severe or end-stage standard
- Physicians may have more room to evaluate symptoms based on current medical needs
- Patients with qualifying conditions may have a clearer path into the program
- The law still keeps access tied to approved medical conditions
This does not mean every patient automatically qualifies. It means the rules may now better match real patient needs.
Adults Over 21 May Now Vaporize Medical Marijuana
SB 220 also changes how approved patients may take medical cannabis. Until now, Georgia patients could access products such as oils, tinctures, capsules, lozenges, topicals, and transdermal patches. The new law adds vaporization as a permitted delivery method for patients who are over 21.
This gives adult patients another option when discussing product use with a physician. Vaporized cannabis may work differently from oral products, so the method of use can matter when patients and doctors discuss timing, symptom patterns, and personal comfort.
The new law expanding access is also clear about what it does not allow. Smoking remains prohibited for all patients. That distinction matters because vaporizing and smoking are treated differently under the law. If you are a patient, you should understand these limits before purchasing or using any cannabis product through the state program. Legal access still depends on following Georgia’s medical cannabis rules.
Georgia’s THC Limits Are Now Measured Differently
Another major part of SB 220 is the change to THC limits. Georgia’s program previously used a 5 percent THC potency cap for medical cannabis products. The new law replaces that with a possession limit of 12,000 milligrams of THC at any one time.
That is a different way to regulate medical cannabis. Instead of focusing only on the percentage of THC in a product, the law now sets a total THC amount that an approved patient may possess. This may give the program more practical flexibility across different product types.
For patients, this is not a signal to guess on dosage or product strength. THC can affect people differently, and medical cannabis should be approached carefully, especially if you take other medications or manage complex symptoms. Seeking a reputable cannabis dispensary informs your decision-making.
DocMJ Provides Medical Marijuana Evaluations To Help You Remain Compliant
At DocMJ, we connect patients with qualified practitioners for professional evaluations. We review your qualifying condition, discuss your symptoms, and explain how the medical cannabis certification process works. As Georgia expands medical marijuana access through SB 220, contact us, and we’ll help you understand your options and complete the required steps legally.
Aaron Bloom, an experienced healthcare attorney, serves as the CEO of DocMJ and Medwell Health and Wellness Centers, where he has overseen the organizations’ mission and growth since 2016. In addition to his leadership roles, Aaron serves on the Board of Directors for Waterfall Bank, bringing his expertise in healthcare, compliance, and strategic growth to the financial services sector.
Aaron’s passion for improving patients’ lives stems from more than 20 years of owning, operating, and representing traditional healthcare organizations. Throughout his career, he has remained committed to finding better ways to relieve suffering and expand access to innovative, patient-centered care. As CEO, Aaron works each day to help patients achieve better health and wellness through the therapeutic benefits of medical cannabis and other evidence-based alternative medicines.